Company intelligence
BridgeBio
We move at the speed of patient need.
About BridgeBio
We exist to bring transformative medicines to people living with genetic conditions. Our model pairs advances in genetic science with an entrepreneurial mindset, enabling us to move with urgency and translate scientific possibility into real-world impact. We’re building leaders as well as transformative medicines, and we’re looking for people driven to push boundaries, solve hard problems, and help patients who can’t wait any longer.
Verified activity
Signals from BridgeBio
6 published signals
Presence & Recognition
BridgeBio shared a personal story about a family facing a rare disease diagnosis through a film produced by Big Think and featuring Noa's parents.
Reported by BridgeBio
Presence & Recognition
BridgeBio shared Adrienne's story on the OnRare Podcast for PKDAwarenessDay
Reported by BridgeBio
Presence & Recognition
BridgeBio's mobile genetic testing van is touring the West Coast bringing no-cost testing directly to ADH1 families.
Reported by BridgeBio
Research & Knowledge
BridgeBio published a new publication in the American Heart Association's Journal of the American Heart Association regarding the joint assessment of sTTR and NT-proBNP for ATTRCM.
Reported by BridgeBio
Presence & Recognition
BridgeBio announced a late-breaking oral presentation on the impact of oral infigratinib on medical complications in achondroplasia from PROPEL 3 at the Annual European Society for Paediatric Endocrinology meeting 2026.
Reported by BridgeBio
Presence & Recognition
BridgeBio will participate in fireside chats at four upcoming healthcare investor conferences scheduled for September 9, 10, 15, and 23.
Reported by BridgeBio